Refractory anemia with excess of blasts
| Refractory anemia' with excess of blasts | |
|---|---|
| Classification and external resources | |
| Specialty | oncology |
| ICD-10 | D46.2 |
| ICD-9-CM | 238.73 |
| ICD-O | M9983/3 |
| MeSH | D000754 |
Refractory anemia with excess of blasts (RAEB) is a type of myelodysplastic syndrome[1] with a marrow blast percentage of 5% to 19%.[2]
In MeSH, "Smoldering leukemia" is classified under RAEB.[3]
References
- ↑ Palmieri S, D'Arco AM, Celentano M, et al. (July 2006). "An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients". Ann. Oncol. 17 (7): 1146–51. doi:10.1093/annonc/mdl083. PMID 16687417.
- ↑ Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M (October 1997). "Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy". Blood 90 (8): 2969–77. PMID 9376577.
- ↑ Leukemia, Smoldering at the US National Library of Medicine Medical Subject Headings (MeSH)
External links
- Smoldering leukemia entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, September 20, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.